Search | TVST | ARVO Journals

Showing 1 – 20 of 38

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Ciliopathy pathways and biomarkers in IRD variant characterisation and therapy steps in retinal organoids

Robyn V Jamieson; To Ha Loi; Anson Cheng; Anai Gonzalez-Cordero; John R Grigg; Nader Aryamanesh; Hani Kim; Pengyi Yang; Benjamin Nash

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1546.

ARVO Annual Meeting Abstract June 2024

Safety, Tolerability, and Efficacy of Tinlarebant from the 24-Month Phase 2 study in Adolescent Patients Affected by Stargardt Disease

John R Grigg; Fred Chen; Ta-Ching Chen; Robyn V Jamieson; Hendrik P Scholl; Michel Michaelides; Jana Zernant; Rando Allikmets; Quan Dong Nguyen; Nathan L Mata

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1026.

ARVO Annual Meeting Abstract June 2024

Longitudinal study of PROM1 IRD variants and review of the literature

William Yates; Benjamin Nash; John R Grigg; Robyn V Jamieson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4731.

ARVO Annual Meeting Abstract June 2024

Attitudes to Gene Therapy for the Eye – A Global Survey

Lauren N Ayton; Myra Mcguinness; Fred Chen; John R Grigg; Heather G Mack; Alexis Ceecee Britten-Jones

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4322.

ARVO Annual Meeting Abstract June 2024

KCNV2 -associated retinopathy natural history and biomarkers using an extended KCNV electrophysiology testing protocol.

Elisa Eleanor Cornish; Dhimas H Sakti; Haipha Ali; Stephanie Retsas; Noona Saakova; Marium Raza; Livia S Carvalho; Benjamin Nash; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5273.

Retina May 2024

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients

PDF

Rachael C. Heath Jeffery; Jennifer A. Thompson; Johnny Lo; Enid S. Chelva; Sean Armstrong; Jose S. Pulido; Rebecca Procopio; Andrea L. Vincent; Lorenzo Bianco; Maurizio Battaglia Parodi; Lucia Ziccardi; Giulio Antonelli; Lucilla Barbano; João P. Marques; Sara Geada; Ana L. Carvalho; Wei C. Tang; Choi M. Chan; Camiel J. F. Boon; Jonathan Hensman; Ta-Ching Chen; Chien-Yu Lin; Pei-Lung Chen; Ajoy Vincent; Anupreet Tumber; Elise Heon; John R. Grigg; Robyn V. Jamieson; Elisa E. Cornish; Benjamin M. Nash; Shyamanga Borooah; Lauren N. Ayton; Alexis Ceecee Britten-Jones; Thomas L. Edwards; Jonathan B. Ruddle; Abhishek Sharma; Rowan G. Porter; Tina M. Lamey; Terri L. McLaren; Samuel McLenachan; Danial Roshandel; Fred K. Chen
TAGS: genetics, phenotype, retinal dystrophies, fundus autofluorescence imaging, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2024; 65(5):22. https://doi.org/10.1167/iovs.65.5.22

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Human stem cell-derived retinal organoids to resolve novel missense and intronic variants of uncertain significance and test novel therapies in the inherited retinal dystrophies

Robyn V Jamieson; To Ha Loi; Fidelle Chahine Karam; John R Grigg; Anson Cheng; Benjamin M Nash

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):479.

ARVO Annual Meeting Abstract June 2023

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease– 15 month preliminary data

John R Grigg; Fred Kuanfu Chen; Ta-Ching Chen; Robyn V Jamieson; Hendrik P Scholl; Nathan L Mata; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2597.

ARVO Annual Meeting Abstract June 2023

IMPDH1 -associated retinitis pigmentosa: natural history and comparison to literature

Dhimas Hari Sakti; Elisa Eleanor Cornish; Benjamin M Nash; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4651.

ARVO Annual Meeting Abstract June 2023

Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio

Chris Ovens; Vannessa Leung; Elisa Eleanor Cornish; Dhimas Hari Sakti; Stephanie Retsas; Haipha Ali; Peter J McCluskey; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5215.

ARVO Annual Meeting Abstract June 2022

GUCY2D-associated autosomal dominant cone-rod dystrophy: Understanding the natural history

Amanda J Scopelliti; Robyn V Jamieson; Elizabeth H Barnes; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):488 – A0065.

ARVO Annual Meeting Abstract June 2022

Improving paediatric uveitis visual outcomes and quality of life.

Sophia Zagora; Tanya Karaconji; Davinder Singh-Grewal; Jeffrey Chaitow; Peter J McCluskey; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3184 – A0410.

ARVO Annual Meeting Abstract June 2022

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects

John R Grigg; Fred Kuanfu Chen; Ta-Ching Chen; Robyn V Jamieson; Nathan L Mata; Webber Liao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3518.

Articles May 2022

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

PDF

Anna M. Waldie; Angharad E. Hobby; Isabelle Chow; Elisa E. Cornish; Mathura Indusegaran; Aleksandra Pekacka; Phuc Nguyen; Clare Fraser; Alison M. Binns; Miles R. Stanford; Christopher J. Hammond; Peter J. McCluskey; John R. Grigg; Omar A. Mahroo
TAGS: electroretinography, mobile devices, photopsia, vitiliginous chorioretinitis, electrophysiology
Trans. Vis. Sci. Tech.. 2022; 11(5):23. https://doi.org/10.1167/tvst.11.5.23

ARVO Annual Meeting Abstract June 2021

Incentives and barriers to diabetic retinopathy screening in Australian general practices

Mohamed Estai; Matthew Watson; Peter J McCluskey; Yogesan Kanagasingam; John R Grigg; Judith Daire

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1131.

ARVO Annual Meeting Abstract June 2021

Ocular Characteristic in a Cohort of Neuronal Ceroid Lipofuscinoses/ Batten Disease Patients

Elisa Eleanor Cornish; Dhimas Hari Sakti; Clare Fraser; Trent Sandercoe; Michael M Jones; Neil A Rowe; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):618.

ARVO Annual Meeting Abstract June 2021

Incidence of electronegative findings in tertiary ophthalmology referral centre

Dhimas Hari Sakti; Haipha Ali; Maria Korsakova; Nonna Saakova; Nina Mustafic; Clare Fraser; Robyn V Jamieson; Elisa Eleanor Cornish; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):614.

ARVO Annual Meeting Abstract June 2021

Aberrant splicing caused by a novel synonymous RPE65 variant, demonstrated in iPSC-derived retinal pigment epithelial cells and on minigene assay

Benjamin Nash; To Ha Loi; Amin Sabri; Steven Eamegdool; Milan Fernando; John R Grigg; Seo-Kyung Chung; Anai Gonzalez-Cordero; Robyn Jamieson

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1453.

ARVO Annual Meeting Abstract June 2021

Paediatric uveitic cataract and glaucoma in the time of biologic therapy

Sophia L Zagora; Tanya Karaconji; Davinder Singh-Grewal; Jeff Chaitow; Robyn Jamieson; Peter J McCluskey; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1410.

ARVO Annual Meeting Abstract June 2021

Optic disc drusen prevalence in the retinitis pigmentosa population

Nicholas Russell; Clare Fraser; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3206.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ciliopathy pathways and biomarkers in IRD variant characterisation and therapy steps in retinal organoids

Safety, Tolerability, and Efficacy of Tinlarebant from the 24-Month Phase 2 study in Adolescent Patients Affected by Stargardt Disease

Longitudinal study of PROM1 IRD variants and review of the literature

Attitudes to Gene Therapy for the Eye – A Global Survey

KCNV2 -associated retinopathy natural history and biomarkers using an extended KCNV electrophysiology testing protocol.

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients

Human stem cell-derived retinal organoids to resolve novel missense and intronic variants of uncertain significance and test novel therapies in the inherited retinal dystrophies

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent Patients Affected by Stargardt Disease– 15 month preliminary data

IMPDH1 -associated retinitis pigmentosa: natural history and comparison to literature

Expanding the phenotype of genetically associated electronegative ERG retinopathies: Comparing the full field ERG b:a ratio

GUCY2D-associated autosomal dominant cone-rod dystrophy: Understanding the natural history

Improving paediatric uveitis visual outcomes and quality of life.

A Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

Incentives and barriers to diabetic retinopathy screening in Australian general practices

Ocular Characteristic in a Cohort of Neuronal Ceroid Lipofuscinoses/ Batten Disease Patients

Incidence of electronegative findings in tertiary ophthalmology referral centre

Aberrant splicing caused by a novel synonymous RPE65 variant, demonstrated in iPSC-derived retinal pigment epithelial cells and on minigene assay

Paediatric uveitic cataract and glaucoma in the time of biologic therapy

Optic disc drusen prevalence in the retinitis pigmentosa population

To View More...

You must be signed into an individual account to use this feature.